Is Your Child's Allowance Undermining Your Retirement?
The $1,000 Challenge, Part 9: Nibbling Away at the Family Food Bills
The Benefits of Filing Your Taxes Early
After Market: Stocks Finish Wild Week with a Whimper
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.